BE SEMICONDUCTOR INDUSTRIES NV Ratio 6 6921 RW Duiven ...

Consolidated Statements of Operations
(euro in thousands, except share and per share data)
Three Months Ended
September 30,
(unaudited)
Nine Months Ended
September 30,
(unaudited)
2009 2008 2009 2008
Revenue 48,704 35,244 94,723 118,835
Cost of sales 32,140 22,407 64,653 77,239
Gross profit 16,564 12,837 30,070 41,596
Acquisition gain/other income 150 41,357
Selling, general and administrative expenses 13,442 9,739 35,482 28,829
Research and development expenses 4,864 3,617 14,616 12,558
Total operating expenses 18,306 13,356 50,098 41,387
Operating income (loss) (1,592) (519) 21,329 209
Financial expense, net (1,116) 974 (2,992) 168
Income (loss) before taxes (2,708) 455 18,337 377
Income tax expense (benefit) 541 43 (537) (132)
Net income (loss) (3,249) 412 18,874 509
Net income per share – basic (0.11) 0.01 0.58 0.02
Net income per share – diluted (0.11) 3)
Number of shares used in computing per share
amounts:
- basic
- diluted
1)
30,815,311
30,815,311 3)
0.01 2)
30,713,529
30,713,529 2)
32,671,721
40,052,084 1)
0.52 1) 0.02 2)
30,713,361
30,713,361 2)
The calculation of the diluted income per share assumes conversion of the Company’s 5.5% outstanding convertible notes due
2012 as such conversion would have a dilutive effect (7,082,927 weighted average equivalent number of ordinary shares).
2) The calculation of the diluted income per share does not assume conversion of the Company’s 5.5% outstanding convertible
notes due 2012 as such conversion would have an anti-dilutive effect (8,975,610 weighted average equivalent number of
ordinary shares).
3) The calculation of the diluted income per share does not assume conversion of the Company’s 5.5% outstanding convertible
notes due 2012 as such conversion would have an anti-dilutive effect (7,082,927 weighted average equivalent number of
ordinary shares).
The financial information has been prepared in accordance with IFRS as adopted by the EU.
(tables to follow)